About Pediatric Bioscience
Pediatric Bioscience is a company based in Sacramento (United States) founded in 2006 by Matt Friesen. It operates as a B2B. Pediatric Bioscience has raised $2.44 million across 2 funding rounds from investors including Tech Coast Angels. Pediatric Bioscience operates in a competitive market with competitors including Linus Biotechnology, Lineagen, SynapDx, MARAbio and SensOmics, among others.
- Headquarter Sacramento, United States
- Founders Matt Friesen
- SectorsHealthcare
- Website pediatricbioscience.com
- Social X
- Total Equity Funding$2.44M (USD)
in 2 rounds
- Latest Funding Round$1.68M (USD), Seed
Mar 2015
- Investors
Funding Insights of Pediatric Bioscience
Pediatric Bioscience has successfully raised a total of $2.44M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.68 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.44M
- Total Rounds 2
- Last Round Seed — $1.68M
- First Round $766,837
(Jul 2014)
- Investors Count 1
All 2 funding rounds of Pediatric Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2015 | $1.68M | Seed | – | – | – |
| Jul 2014 | $766,837 | Seed | – | Tech Coast Angels | – |
1 investors in total: 1 institutional.
Investors in Pediatric Bioscience
Pediatric Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Tech Coast Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Angel Network for companies based in Southern California | – | techcoastangels.com | Los Angeles, United States |
Investor details for Pediatric Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pediatric Bioscience
1 people are tracked at Pediatric Bioscience (1 in leadership).
| Name | Role | Group |
|---|---|---|
Matt Friesen | Co-Founder, COO | Leadership |
Complete people profiles for Pediatric Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pediatric Bioscience
3 dated milestones of Pediatric Bioscience across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Pediatric Bioscience is founded.
- Funding First funding round of $767K.
- Funding Latest funding round, Seed, of $1.7M.
Competitors of Pediatric Bioscience
Pediatric Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Linus Biotechnology, Lineagen, SynapDx, MARAbio and SensOmics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| linusbio.com | 2020 | New York, United States | $47.65M | – | Developer of diagnostic tests for central nervous system and gastrointestinal disorders | |
| lineagen.com | 2002 | Salt Lake, United States | $66.93M | 40 | Sequencing-based diagnostic tests and services for autism are provided. | |
| synapdx.com | 2010 | Southborough, United States | $32.75M | – | Online platform offering HGH injections for energy, performance, and anti-aging. | |
| marabio.com | 2016 | Salt Lake, United States | $19.06M | – | A blood test for maternal autoantibody-related autism is developed. | |
| sensomics.com | 2007 | Toronto, Canada | – | – | Precision medicine for children's health is provided through genomic integration. | |
| neuropointdx.com | 2006 | Madison, United States | – | – | Metabolomics for neuro-developmental disorders | |
| autism-biotech.com | 2011 | Belfast, United Kingdom | $51,300 | – | Develops biochemical tests for early autism diagnosis. | |
| fbbbio.com | 2020 | Coralville, United States | $401,000 | – | In-vitro diagnostic tests for COVID-19 and neurological diseases are developed. | |
| neuraclegen.com | 2018 | Seoul, South Korea | – | – | Develops gene therapies using adeno-associated virus technology to treat various diseases. |
Detailed competitors of Pediatric Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Pediatric Bioscience
10 companies that operate in the same segment as Pediatric Bioscience (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pediatric Bioscience
Pediatric Bioscience was founded in 2006 and raised its 1st funding round 8 years after it was founded.
Pediatric Bioscience is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Pediatric Bioscience is a funded company, having raised a total of $2.44M across 2 funding rounds to date. The company's 1st funding round was a Seed of $766.84K, raised on Jul 2014.
Pediatric Bioscience, established in 2006, excels in providing healthcare solutions, advancing biotech innovations, medical diagnostics, and neurological disorders. Provides blood biomarker-based diagnostics for autism spectrum disorders. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Pediatric Bioscience's top competitors include Linus Biotechnology, MARAbio and Lineagen.
Pediatric Bioscience has 1 investor. Key investors include Tech Coast Angels.